Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

por Chalmers, Z R, Ali, S M, Ohgami, R S, Campregher, P V, Frampton, G M, Yelensky, R, Elvin, J A, Palma, N A, Erlich, R, Vergilio, J-A, Chmielecki, J, Ross, J S, Stephens, P J, Hermann, R, Miller, V A, Miles, C R
Publicado 2015